drugset / Trial / NCT00847054

A Study of of MORAb-004 in Subjects With Solid Tumors

NCT00847054 ↗

Phase 1 Completed 80 enrolled Morphotek
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the safety of multiple intravenous infusions of MORAb-004.

Timeline

Start
2009-03
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Ontuxizumab Monoclonal antibody — Intravenous

Indications